Brief: Orthocell Says Market Expansion Of Remplir Will Be Accelerated
22/01/2025 01:31
Jan 22 (Reuters) - Orthocell Ltd OCC.AX :
* MARKET EXPANSION OF REMPLIR WILL BE ACCELERATED AHEAD OF
US FDA
CLEARANCE EXPECTED IN MARCH/APRIL 2025
Source text: ID:nASX3PzXhn
Further company coverage: OCC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orthocell
See all newsBrief: Orthocell Reports September Quarter Revenue Of A$3.6 Million
Australia's Orthocell rises as flagship product records first Thailand sales
Brief: Orthocell Says QTRLY A$3.2 Million Revenue Achieved
Australia's Orthocell set for best week since November 2024 on US DoD approval for key product
Brief: Orthocell's First Surgical Use Of Remplir In US Department Of Defense